IRIDEX CorpNASDAQ:IRIX
- LAST PRICE2.0700
- TODAY'S CHANGE (%)0.0400 (1.9704%)
- Bid / Lots1.9000/ 2
- Ask / Lots2.4500/ 1
- Open / Previous Close2.0200 / 2.0300
- Day Range
- 52 Week Range
- Volume11,536
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IRIX |
|---|---|---|
| 09:32 ET | 105 | 2.02 |
| 09:41 ET | 1147 | 2.02 |
| 11:47 ET | 2493 | 2.01 |
| 11:49 ET | 1877 | 2.09 |
| 12:45 ET | 100 | 2.06 |
| 01:37 ET | 100 | 2.111 |
| 02:47 ET | 282 | 2.08 |
| 03:00 ET | 500 | 2.055 |
| 03:52 ET | 1266 | 2.07 |
| 03:54 ET | 1500 | 2.07 |
| 03:56 ET | 950 | 2.07 |
Mar 9, 2023
BRIEF-Iridex Reports Fourth Quarter And Full Year 2022 Financial Results, from 5:05PM ET on Thursday Mar 09, 2023 by Thomson Reuters
5:05PM ET on Thursday Mar 09, 2023 by Thomson Reuters-- Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q4 Revenue $15.2M, vs. Street Est of $15.16M, from 4:12PM ET on Thursday Mar 09, 2023 by MT Newswires
4:12PM ET on Thursday Mar 09, 2023 by MT NewswiresIridex Reports Fourth Quarter and Full Year 2022 Financial Results, from 4:05PM ET on Thursday Mar 09, 2023 by GlobeNewswire
4:05PM ET on Thursday Mar 09, 2023 by GlobeNewswire
Mar 7, 2023
Iridex to Present at the 35th Annual Roth Conference, from 4:05PM ET on Tuesday Mar 07, 2023 by GlobeNewswire
4:05PM ET on Tuesday Mar 07, 2023 by GlobeNewswire
Mar 2, 2023
Iridex Introduces New Research and Showcases Five Events at the AGS Meeting, from 9:00AM ET on Thursday Mar 02, 2023 by GlobeNewswire
9:00AM ET on Thursday Mar 02, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
IRIDEX Corp | 32.5M | -4.4x | --- |
NantHealth Inc | 14.6M | -3.9x | --- |
Vapotherm Inc | 25.8M | -0.1x | --- |
Chembio Diagnostics Inc | 13.6M | -0.3x | --- |
Owlet Inc | 39.1M | -0.5x | --- |
Dynatronics Corp | 6.5M | -3.3x | --- |
Company Information
Iridex Corporation is an ophthalmic medical technology company, which is focused on the development and commercialization of products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. The Company’s laser consoles products consist of Glaucoma, which includes Cyclo G6 laser and delivery devices used for the treatment of glaucoma; Medical Retina product, which includes IQ 532 Laser and IQ 577 Laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases, and its PASCAL Synthesis Photocoagulator for the treatment of retinal diseases; Surgical Retina, which includes OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL and OcuLight GLx laser photocoagulation systems. Its laser probes products consist of Glaucoma, which include MicroPulse P3 Probe, G-Probe and G-Probe Illuminate, and Surgical Retina probes, which include EndoProbe family of products used in vitrectomy procedures.
Contact Information
- Headquarters
- 1212 Terra Bella AveMOUNTAIN VIEW, CA, United States 94043-1824
- Phone
- 650-940-4700
- Fax
- 650-940-4710
Executives
- Independent Chairman of the Board
- Scott Shuda
- President, Chief Executive Officer, Director
- David Bruce
- Interim Chief Financial Officer
- Fuad Ahmad
- Chief Operating Officer
- Patrick Mercer
- Director
- Beverly Huss
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $32.5M |
|---|---|
Revenue (TTM) | $57.0M |
Shares Outstanding | 16.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.27 |
EPS | $-0.47 |
Book Value | $1.08 |
P/E Ratio | -4.4x |
Price/Sales (TTM) | 0.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -13.24% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
